CenterWatch

Clinical Trial Details

Overview

Research Study Summary

Diabetes Shouldn’t Define You

Purpose

Diabetes impacts the lives of millions of people each year, but it shouldn’t define who you are. If you’ve been diagnosed with type 2 diabetes and are overweight you may already know how important it is to monitor your blood sugar, eat healthy and be active.

Physicians in your area are studying an investigational medication compared to an already approved medication in the treatment of type 2 diabetes.

Eligible participants are overweight and have type 2 diabetes. To qualify you must also be taking Metformin for the treatment of diabetes for at least 3 months. Patients receiving treatment with other diabetes medications within the past 3 months will not be allowed.

If you qualify, you will receive all study-related care, including physical exams, lab services, and study medications. During participation you will remain on a dose of Metformin.

For more information please call Diablo Clinical Research at 925-930-7267 or visit our website at www.diabloclinical.com

To Learn more

CW ID:156504
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

For more information please call Diablo Clinical Research at 925-930-7267 or visit our website at www.diabloclinical.com

Diablo Clinical Research
2255 Ygnacio Valley Rd
Walnut Creek, CA 94598
Phone: 925-930-7267

View Map

Research Center Information: Diablo Clinical Research

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.